Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Change in Inventory (2020 - 2023)

Palatin Technologies' (PTN) quarterly Change in Inventory came in at $2.2 million in Q4 2023, up 2155.77% on a YoY basis from $98707.0 in Q4 2022, and up 307.66% quarter-over-quarter from -$1.1 million in Q3 2023.

Analysis

Palatin Technologies (PTN) Change in Inventory (2020 - 2023) Analysis & Trends

Palatin Technologies (PTN) has reported Change in Inventory for 4 consecutive years, with $2.2 million the latest figure, recorded in Q4 2023.

  • For the quarter ending Q4 2023, Change in Inventory rose 2155.77% year-over-year to $2.2 million; the trailing twelve-month figure through Sep 2024 stood at $2.2 million (up 400.78% YoY), and the FY2024 full-year result was $1.2 million, up 175.85% from the prior year.
  • Change in Inventory advanced to $2.2 million in Q4 2023 per PTN's latest filing, from -$1.1 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $2.2 million in Q4 2023 and bottomed at -$1.1 million in Q3 2023.
  • Historically, Change in Inventory has averaged $198399.4 across 4 years, with a median of $92601.5 in 2022.
  • The widest YoY moves for Change in Inventory: up 2155.77% in 2023, down 1339.65% in 2023.
  • Over 4 years, Change in Inventory stood at $188093.0 in 2020, then sank by 172.86% to -$137037.0 in 2021, then soared by 172.03% to $98707.0 in 2022, then surged by 2155.77% to $2.2 million in 2023.
  • According to Business Quant data, Change in Inventory over the past three periods registered $2.2 million, -$1.1 million, and $104033.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 31.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 145.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 27.70 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 28.20 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 132.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -280,000.00
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -75.70 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Palatin Technologies 46.98 Mn 46.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 2.23 Mn
Sep 30, 2023 -1.07 Mn
Jun 30, 2023 104,033.00
Mar 31, 2023 129,235.00
Dec 31, 2022 98,707.00
Sep 30, 2022 86,496.00
Jun 30, 2022 347,541.00
Mar 31, 2022 -46,908.00
Dec 31, 2021 -137,037.00
Sep 30, 2021 53,933.00
Jun 30, 2021 1.28 Mn
Mar 31, 2021 -510,216.00
Dec 31, 2020 188,093.00
Sep 30, 2020 25,200.00